PFBT
ANAB icon

Parkside Financial Bank & Trust’s AnaptysBio ANAB Stock Holding History

Parkside Financial Bank & Trust’s Portfolio ANAB Stock Details ANAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.69K Hold
25
– – ﹤0.01% 2242
2026
Q1 		$1.39K Hold
25
– – ﹤0.01% 2235
2025
Q4 		$1.21K Hold
25
– – ﹤0.01% 2275
2025
Q3 		$766 Hold
25
– – ﹤0.01% 2384
2025
Q2 		$555 Buy
+25
New +$523 ﹤0.01% 2482

Other funds holding ANAB

EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Woodline Partners
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

Parkside Financial Bank & Trust's ANAB Position: Q2 2026 in Review

Parkside Financial Bank & Trust held its AnaptysBio (ANAB) position steady in Q2 2026 at 25 shares worth $1.69K. The position accounts for ﹤0.01% of the portfolio, ranked #2242.

Parkside Financial Bank & Trust first reported a position in ANAB in Q2 2025 and has held it in 5 quarters since. 213 funds tracked by Wall St. Rank hold ANAB as of Q2 2026.

  • Parkside Financial Bank & Trust held 25 shares of AnaptysBio worth $1.69K as of Q2 2026.
  • Parkside Financial Bank & Trust left its AnaptysBio share count unchanged in Q2 2026.
  • AnaptysBio made up ﹤0.01% of Parkside Financial Bank & Trust's portfolio in Q2 2026, its #2242 holding.
  • Parkside Financial Bank & Trust first reported a position in AnaptysBio in Q2 2025 and has held it in 5 quarters since.
  • 213 funds tracked by Wall St. Rank held AnaptysBio as of Q2 2026.

Based on Parkside Financial Bank & Trust's 13F filing for Q2 2026, filed 4 Sep 2026.